Vinorelbine, Ifosfamide and Cisplatin in Advanced Non-Small Cell Lung Cancer

By Tan Eng-Huat   Ang Peng Tiam   Wee Joseph   Fong Kam Weng   Leong Swan Swan   Khoo Kei Siong  

Acta Oncologica, Vol. 38, Iss. 5, 1999-06 ,pp. : 619-622

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite

Combination of Cisplatin and Interferon- 2a (Roferon(R)-A) in Patients with Non-small Cell Lung Cancer (NSCLC). An Open Phase II Multicentre Study

By Kataja V.   Yap A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

By Kroep J.   Smit E.   Giaccone G.   Born K.   Beijnen J.   Groeningen C.   Vijgh W.   Postmus P.   Pinedo H.   Peters G.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 509-516

Springer Publishing Company

Access to resources Recommend Favorite

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

By                                  

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 465-470

Spandidos Publications

Access to resources Recommend Favorite